» Articles » PMID: 18711148

A Functional Polymorphism in the MiR-146a Gene is Associated with the Risk for Hepatocellular Carcinoma

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2008 Aug 20
PMID 18711148
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

A G > C polymorphism (rs2910164) is located in the stem region opposite to the mature miR-146a sequence, which results in a change from G:U pair to C:U mismatch in the stem structure of miR-146a precursor. Here, we elucidated the biological significance of this polymorphism, based on cancer association study and cell model system. The cancer association study included 479 hepatocellular carcinoma (HCC) and 504 control subjects. We found that the genotype distribution of this polymorphism in HCC cases was significantly different from that in control subjects (P = 0.026). The association between the genotype and the risk of HCC was further analyzed using multivariate unconditional logistic regression, with adjustment for sex, age and hepatitis B virus status. The results revealed that male individuals with GG genotype were 2-fold more susceptible to HCC (odds ratio = 2.016, 95% confidence interval = 1.056-3.848, P = 0.034) compared with those with CC genotype. We next examined the influence of this polymorphism on the production of mature miR-146a and found that G-allelic miR-146a precursor displayed increased production of mature miR-146a compared with C-allelic one. Further investigations disclosed that miR-146a could obviously promote cell proliferation and colony formation in NIH/3T3, an immortalized but non-transformed cell line. These data suggest that the G > C polymorphism in miR-146a precursor may result in important phenotypic traits that have biomedical implications. Our findings warrant further investigations on the relation between microRNA polymorphism and human diseases.

Citing Articles

MicroRNA-146: Biomarker and Mediator of Cardiovascular Disease.

Mahdavi F, Mardi S, Mohammadi S, Ansari S, Yaslianifard S, Fallah P Dis Markers. 2024; 2022:7767598.

PMID: 39281713 PMC: 11401689. DOI: 10.1155/2022/7767598.


The Association between Four Common Polymorphisms in microRNA and Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis.

Chen M, Lu Y, Wang X, Qin S, Chen H, Lu L Iran J Public Health. 2023; 52(11):2272-2285.

PMID: 38106842 PMC: 10719708. DOI: 10.18502/ijph.v52i11.14027.


Prospective Functions of miRNA Variants May Predict Breast Cancer Among Saudi Females.

Ekram S, Alghamdi G, Elhawary A, Sembawa H, Noorwali A, Sindi I Cureus. 2023; 15(10):e47849.

PMID: 37899898 PMC: 10611986. DOI: 10.7759/cureus.47849.


MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.

Mendiola-Soto D, Barcenas-Lopez D, Perez-Amado C, Cruz-Miranda G, Mejia-Arangure J, Ramirez-Bello J Int J Mol Sci. 2023; 24(6).

PMID: 36982511 PMC: 10049736. DOI: 10.3390/ijms24065436.


Role of miR-143 and miR-146 in Risk Evaluation of Coronary Artery Diseases in Autopsied Samples.

Tie J, Takanari H, Ota K, Okuda T Genes (Basel). 2023; 14(2).

PMID: 36833398 PMC: 9956587. DOI: 10.3390/genes14020471.